default author photo

Yoon-La Choi

Sungkyunkwan University - Samsung Medical Center

81, Irwon- Ro

Gangnam-gu

Seoul, 135-710

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

5

DOWNLOADS

301

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

The Role of APOBEC in Early-Stage Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer

Number of pages: 22 Posted: 04 Dec 2024
Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - School of Medicine, Sungkyunkwan University - Samsung Medical Center and Sungkyunkwan University - Samsung Medical Center
Downloads 79 (809,932)

Abstract:

Loading...

Non-small cell lung cancer, APOBEC, EGFR-TKI

2.

The role of APOBEC in Early-Stage Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer

Number of pages: 22 Posted: 12 Sep 2024
Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - School of Medicine, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center and Sungkyunkwan University - Samsung Medical Center
Downloads 79 (809,932)

Abstract:

Loading...

Non-small cell lung cancer, APOBEC, EGFR-TKI

3.

Does the Adjuvant Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Change the Natural History of Resected EGFR Mutation-Positive Non-Small Cell Lung Cancer? Is it for Prime Time?

Number of pages: 29 Posted: 19 Nov 2021
Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University, Sungkyunkwan University - Samsung Medical Center, CHA University, Sungkyunkwan University - Department of Thoracic and Cardiovascular Surgery, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - School of Medicine, Sungkyunkwan University - Samsung Medical Center and Sungkyunkwan University - Samsung Medical Center
Downloads 70 (875,328)

Abstract:

Loading...

Non-Small-Cell Lung Carcinoma, Epidermal Growth Factor Receptor, Whole-Exome Sequencing, Adjuvant, Personalized

4.

Different Prognostic Role of EGFR Mutation According to the IASLC Histologic Grade in Patients with Resected Early-Stage Lung Adenocarcinoma

Number of pages: 25 Posted: 06 Dec 2022
Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Department of Thoracic and Cardiovascular Surgery, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Department of Laboratory Medicine and Genetics, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Department of Clinical Research Design and Evaluation and Sungkyunkwan University - Samsung Medical Center
Downloads 59 (970,490)

Abstract:

Loading...

lung adenocarcinoma, early stage, Prognosis, EGFR mutation, histologic grade

5.

Management for Radiologic N0 Non-Small Cell Lung Cancer: Strategic Approach Based on the Incidence of Unexpected N2 Disease and Long-Term Survival

Number of pages: 30 Posted: 08 Jul 2025
Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Seoul National University - Graduate School of Public Health, affiliation not provided to SSRN, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Department of Laboratory Medicine and Genetics, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center and Sungkyunkwan University - Samsung Medical Center
Downloads 14 (1,509,872)

Abstract:

Loading...

Lung resection, radiologic N0 disease, unexpected N2 Disease, Lung cancer